Prevention of T-cell activation by rhCTLA4-Ig and anti-CD40L monoclonal antibody results in indefinite islet allograft survival

C. Rastellini, A. Salam, R. Kuddus, A. Aitouche, V. Subbotin, M. Braun, R. Leach, R. Peach, J. J. Fung, T. E. Starzl, A. S. Rao

Research output: Contribution to journalArticlepeer-review

13 Scopus citations

Fingerprint

Dive into the research topics of 'Prevention of T-cell activation by rhCTLA4-Ig and anti-CD40L monoclonal antibody results in indefinite islet allograft survival'. Together they form a unique fingerprint.